XML 36 R24.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Reporting
9 Months Ended
Sep. 30, 2025
Segment Reporting  
Segment Reporting

15.

Segment Reporting

For purposes of evaluating performance and allocating resources, the Company’s CODM, its Chief Executive Officer, regularly reviews consolidated net loss as reported in the Company’s consolidated statements of operations and comprehensive loss as compared to budget. The measure of segment assets is reported in the consolidated balance sheets as total consolidated assets.

In addition to the significant expense categories included within net loss presented in the Company’s unaudited condensed consolidated statements of operations and comprehensive loss, see below for disaggregated amounts that comprise research and development expenses for the three and nine months ended September 30, 2025 and 2024 (in thousands):

    

Three Months Ended September 30, 

    

Nine Months Ended September 30, 

    

2025

    

2024

    

2025

    

2024

 

Revenue:

License revenue

$

$

$

17,389

$

Collaboration revenue

2,066

4,732

Total revenue

2,066

22,121

Operating expenses:

Research and development expenses

External costs

Milestones related to previously acquired IPR&D assets

23,000

23,000

CROs, CMOs and clinical trials

56,457

39,491

187,618

90,604

Professional consulting services

8,227

4,497

22,047

12,787

Other research and development costs

1,617

2,899

6,908

8,493

Internal costs

Personnel-related costs

24,854

13,476

69,334

32,705

Facilities and overhead costs

6,681

4,461

17,306

10,761

Total research and development expense

97,836

87,824

303,213

178,350

General and administrative expenses

19,522

10,575

76,267

23,782

Total operating expenses

 

117,358

 

98,399

 

379,480

 

202,132

Loss from operations

 

(115,292)

 

(98,399)

 

(357,359)

 

(202,132)

Total other income (expense), net

4,540

5,282

 

198,404

 

2,658

Net loss before income taxes

(110,752)

(93,117)

(158,955)

(199,474)

Income tax benefit

8,561

Net loss

$

(110,752)

$

(93,117)

$

(150,394)

$

(199,474)